1. Home
  2. ALVOW vs TGL Comparison

ALVOW vs TGL Comparison

Compare ALVOW & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • TGL
  • Stock Information
  • Founded
  • ALVOW 2013
  • TGL 2020
  • Country
  • ALVOW Luxembourg
  • TGL United States
  • Employees
  • ALVOW 999
  • TGL N/A
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • ALVOW Health Care
  • TGL Technology
  • Exchange
  • ALVOW Nasdaq
  • TGL Nasdaq
  • Market Cap
  • ALVOW N/A
  • TGL N/A
  • IPO Year
  • ALVOW N/A
  • TGL 2022
  • Fundamental
  • Price
  • ALVOW $1.36
  • TGL $0.07
  • Analyst Decision
  • ALVOW
  • TGL
  • Analyst Count
  • ALVOW 0
  • TGL 0
  • Target Price
  • ALVOW N/A
  • TGL N/A
  • AVG Volume (30 Days)
  • ALVOW 15.0K
  • TGL 11.6M
  • Earning Date
  • ALVOW 02-27-2025
  • TGL 05-13-2025
  • Dividend Yield
  • ALVOW N/A
  • TGL N/A
  • EPS Growth
  • ALVOW N/A
  • TGL N/A
  • EPS
  • ALVOW N/A
  • TGL N/A
  • Revenue
  • ALVOW $393,919,000.00
  • TGL $2,398,398.00
  • Revenue This Year
  • ALVOW N/A
  • TGL N/A
  • Revenue Next Year
  • ALVOW N/A
  • TGL N/A
  • P/E Ratio
  • ALVOW N/A
  • TGL N/A
  • Revenue Growth
  • ALVOW 517.92
  • TGL N/A
  • 52 Week Low
  • ALVOW $2.33
  • TGL $0.06
  • 52 Week High
  • ALVOW $2.33
  • TGL $6.04
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • TGL 23.70
  • Support Level
  • ALVOW N/A
  • TGL $0.09
  • Resistance Level
  • ALVOW N/A
  • TGL $0.11
  • Average True Range (ATR)
  • ALVOW 0.00
  • TGL 0.02
  • MACD
  • ALVOW 0.00
  • TGL -0.00
  • Stochastic Oscillator
  • ALVOW 0.00
  • TGL 8.52

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: